Table 2.
Spearman’s | FIGO | Grade | T | LN | M | L | hTra2β1 | |
---|---|---|---|---|---|---|---|---|
(I/II vs III/IV) | (1/2 vs 3) | (P vs N) | (P vs N) | (P vs N) | mRNA | |||
ERα standard | correlation | −0222* | −0.317** | N.S | N.S | N.S | N.S | −0.214* |
coefficient | ||||||||
p (2-tailed) | 0.033 | 0.001 | N.S | N.S | N.S | N.S | 0.022 | |
N | 92 | 116 | 116 | 109 | 86 | 50 | 115 | |
ERα∆7 | correlation | −0.223* | −0.203* | N.S | −0.206* | N.S | −0.332* | −0.168 |
coefficient | ||||||||
p (2-tailed) | 0.033 | 0.029 | N.S | 0.032 | N.S | 0.019 | 0.073 | |
N | 92 | 116 | 116 | 109 | 86 | 50 | 116 | |
ERα∆7/standard | correlation | −0.251* | −0.227* | N.S | −0.232* | N.S | −0.407** | −0.198** |
coefficient | ||||||||
p (2-tailed) | 0.016 | 0.014 | N.S | 0.015 | N.S | 0.003 | 0.0034 | |
N | 92 | 116 | 116 | 109 | 86 | 50 | 116 |
T = Primary tumor; LN = lymph node metastasis; M = distant organ metastasis; L = lymphangiosis; P = positive; N = negative; p = p value; N.S = Not significant; * = significant at the 0.05 level (2-tailed); ** = significant at the 0.001 level.